Piramal Pharma’s Telangana unit starts production of general anesthesia drug Sevoflurane

Piramal Pharma said that it has commenced the commercial production of Sevoflurane at the company’s facility located at Digwal, Telangana, India.

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility in addition to existing capabilities at the Companys facility at Bethlehem, Pennsylvania, USA.

“This would boost the companys capability to also tap into Inhalation Anesthesia opportunities in the ROW markets in addition to the USA markets, Piramal Pharma said in a statement.

Piramal Pharma (PPL) is a part of the Piramal group of companies. The pharmaceutical product portfolio of the company can be categorised into contract development and manufacturing organisations (CDMO), complex hospital generics (critical care), and consumer healthcare (OTC).

Related Posts

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Hyderabad – A groundbreaking study by the Indian Council of Medical Research’s National Institute of Nutrition (ICMR-NIN) has established a clear association between micronutrient deficiencies and elevated dementia risk among Indian…

Pvt nursing home sealed in Chatra after woman, unborn baby die

Chatra: The Chatra administration on Sunday sealed a private nursing home operating near Chatra bus stand following the death of a 20-year-old pregnant woman and her unborn child. The deceased…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Drug companies directed to step up vigil on adverse reactions

Drug companies directed to step up vigil on adverse reactions

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities